Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:26 pm Unchanged | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | LAV Biosciences Fund V L.P. | 25,406,680 5.3% | 0 (Unchanged) | View |
| 2024-02-13 5:23 pm Purchase | 13G | BURNING ROCK BIOTECH LTD SPONS BNR | LAV Biosciences Fund V L.P. | 4,384,205 5.1% | 4,384,205 (New Position) | View |
| 2024-02-13 5:21 pm Unchanged | 13G | TERNS PHARMACEUTICALS INC TERN | LAV Biosciences Fund V L.P. | 2,901,566 4.7% | 0 (Unchanged) | View |
| 2023-02-06 2:45 pm Sale | 13G | TERNS PHARMACEUTICALS INC TERN | LAV Biosciences Fund V L.P. | 2,901,566 6.1% | -63,304 (-2.14%) | View |
| 2022-12-29 2:57 pm Sale | 13G | TERNS PHARMACEUTICALS INC TERN | LAV Biosciences Fund V L.P. | 2,964,870 6.18% | -1,816,696 (-37.99%) | View |
| 2022-02-09 12:29 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | LAV Biosciences Fund V L.P. | 4,781,566 18.9% | 4,781,566 (New Position) | View |
| 2022-02-09 12:17 pm Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | LAV Biosciences Fund V L.P. | 25,406,680 7.8% | 25,406,680 (New Position) | View |